Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 4/20 | 0.68 |
| ▸ | PPARG | P37231 | 4/20 | 0.68 |
| ▸ | ALOX5 | P09917 | 13/20 | 0.67 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.61 |
| ▸ | PTGES | O14684 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2290615 | 1.00 | PPARA (0.68) | PPARAPPARGALOX5NR1I2PTGES | |
| SCHEMBL2290607 | 1.00 | PPARA (0.68) | PPARAPPARGALOX5NR1I2PTGES | |
| SCHEMBL2365075 | 0.94 | PPARA (0.61) | PPARAPPARGALOX5NR1I2PTGES | |
| SCHEMBL2365077 | 0.94 | PPARA (0.61) | PPARAPPARGALOX5NR1I2PTGES | |
| SCHEMBL2292160 | 0.87 | ALOX5 (0.60) | PPARAPPARGALOX5NR1I2PTGES | |
| SCHEMBL2292170 | 0.87 | ALOX5 (0.60) | PPARAPPARGALOX5NR1I2PTGES | |
| SCHEMBL2292165 | 0.87 | ALOX5 (0.60) | PPARAPPARGALOX5NR1I2PTGES | |
| SCHEMBL26188784 | 0.86 | PPARA (0.66) | PPARAPPARGALOX5NR1I2PTGES | |
| SCHEMBL16077002 | 0.85 | PPARA (0.81) | PPARAPPARGALOX5NR1I2PTGES | |
| SCHEMBL16136832 | 0.85 | PPARA (0.69) | PPARAPPARGALOX5NR1I2PTGES |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8969303-B2 | Tocotrienol esters | FIRST TECH INTERNATIONAL LIMITED (CN) | 2015-03-03 | — | — | US | claimed |
| EP-2531028-B1 | TOCOTRIENOL ESTERS | FIRST TECH INTERNAT LTD (CN) | 2014-12-31 | — | — | EP | claimed |
| US-20110196030-A1 | TOCOTRIENOL ESTERS | FIRST TECH INTERNATIONAL LIMITED (CN) | 2011-08-11 | — | — | US | claimed |
| US-8969303-B2 | Tocotrienol esters | FIRST TECH INTERNATIONAL LIMITED (CN) | 2015-03-03 | — | — | US | disclosed |
| EP-2531028-B1 | TOCOTRIENOL ESTERS | FIRST TECH INTERNAT LTD (CN) | 2014-12-31 | — | — | EP | disclosed |
| US-20110196030-A1 | TOCOTRIENOL ESTERS | FIRST TECH INTERNATIONAL LIMITED (CN) | 2011-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110196030-A1 | TOCOTRIENOL ESTERS | TTPA, MBOAT1, TBXAS1 | PPARA 520/4885PPARG 359/4885ALOX5 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.